New edaravone tablet tested against existing forms in healthy volunteers
NCT ID NCT06107205
First seen May 03, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study tested whether a new tablet form of edaravone (TTYP01) works similarly to the existing injection and oral suspension forms in healthy adults. 29 participants took each form in a random order under fasting conditions. The goal was to compare how the drug is absorbed and to check safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Early Phase Services
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.